Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn how to choose between price and TRI indices for benchmarking your investments. This quick intro explains key differences and why the right choice matters for performance comparison.
27,883 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Direxion has unveiled SKHL, a 2X leveraged ETF tied to SK hynix, signaling a new foray into the memory-chip space. Th...
Braze stock surged today as the marketing-tech player highlighted AI-driven growth and stronger customer engagement m...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
SanDisk is leading a powerful memory-chip rally, jumping 558% this year as AI-driven data-center demand reshapes expe...
Wingstop has slumped 60% in the last year amid a negative equity balance sheet. Meanwhile, three asset-heavy stocks—r...
California lawmakers move to tighten a five-year-old starter-home law, with SB 1116 clearing the Senate 37-0 and head...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
As the Fed stays steady on rates, investors debate whether crypto should be bought before or after the next rate cut....
A proposed state ban on institutional buyers could change how Californians get loans for homes and how lenders price ...
Tesla accelerates margin gains in Q1 2026 as Rivian pushes its R2 strategy through partnerships and new products, hig...
Netflix beat revenue but faced a big one-time charge, boosting cash flow guidance. Spotify posted a strong EPS beat b...